日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency

SLC6A8 变异的新型校正剂:肌酸转运蛋白缺乏症的治疗机会

Lara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, Matthew T Labenski, Victor Rusu, Lea Rosskamp, Leslie Conway, Daniel van Kalken, Liam Gross, Gianna Iantosca, William Crotty, Robert Mathis, Hyejin Park, Benjamin Rabin, Christina Westgate, Matthew Lyons, Chloe Deshusses, Nicholas Brandon,

In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing

不可逆突变选择性 EGFR 抑制剂(保留野生型)的体外和体内表征

Robert Tjin Tham Sjin, Kwangho Lee, Annette O Walter, Aleksandr Dubrovskiy, Michael Sheets, Thia St Martin, Matthew T Labenski, Zhendong Zhu, Richland Tester, Russell Karp, Aravind Medikonda, Prasoon Chaturvedi, Yixuan Ren, Henry Haringsma, Jeff Etter, Mitch Raponi, Andrew D Simmons, Thomas C Hardin

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans

使用 CC-292 抑制 Btk 可对小鼠和人类的活性进行早期药效学评估

Erica K Evans, Richland Tester, Sharon Aslanian, Russell Karp, Michael Sheets, Matthew T Labenski, Steven R Witowski, Heather Lounsbury, Prasoon Chaturvedi, Hormoz Mazdiyasni, Zhendong Zhu, Mariana Nacht, Martin I Freed, Russell C Petter, Alex Dubrovskiy, Juswinder Singh, William F Westlin

The frequency of 1,4-benzoquinone-lysine adducts in cytochrome c correlate with defects in apoptosome activation

细胞色素 c 中 1,4-苯醌-赖氨酸加合物的频率与凋亡小体活化缺陷相关

Ashley A Fisher, Matthew T Labenski, Srinivas Malladi, John D Chapman, Shawn B Bratton, Terrence J Monks, Serrine S Lau